Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mifepristone: bioavailability, pharmacokinetics and use-effectiveness.

N N Sarkar1

  • 1Department of Reproductive Biology, All India Institute of Medical Sciences, Ansarinagar, 110029, New Delhi, India.

European Journal of Obstetrics, Gynecology, and Reproductive Biology
|February 23, 2002
PubMed
Summary

Mifepristone (RU486) effectively terminates early pregnancies and acts as a post-coital contraceptive. Lower doses show high efficacy with fewer side effects, suggesting optimized use for reproductive health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The cause and consequence of domestic violence on pregnant women in India.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2013
Same author

The emergency contraceptive drug, levonorgestrel: a review of post-coital oral and peri-coital vaginal administration for prevention of pregnancy.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2011
Same author

Barriers to emergency contraception (EC): does promoting EC increase risk for contacting sexually transmitted infections, HIV/AIDS?

International journal of clinical practice·2009
Same author

The impact of intimate partner violence on women's reproductive health and pregnancy outcome.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2008
Same author

Barriers to condom use.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2008
Same author

Intracytoplasmic sperm injection: an assisted reproductive technique and its outcome to overcome infertility.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2007

Area of Science:

  • Pharmacology
  • Reproductive Endocrinology

Background:

  • Mifepristone (RU486) is an orally active antiprogestogen and antiglucocorticoid.
  • Its pharmacokinetic profile, including absorption, bioavailability, and metabolism, influences its efficacy.
  • Understanding its mechanism of action is crucial for its application in reproductive medicine.

Purpose of the Study:

  • To review the potential of mifepristone as an abortifacient and contraceptive.
  • To analyze its pharmacokinetic parameters and clinical efficacy.
  • To evaluate its safety and side effect profile.

Main Methods:

  • Review of existing literature on mifepristone's pharmacology and clinical trials.
  • Analysis of pharmacokinetic data, including absorption, distribution, metabolism, and excretion.

Related Experiment Videos

  • Evaluation of efficacy and safety data from studies on early pregnancy termination and contraception.

    • Main Results:

    • Mifepristone exhibits significant abortifacient and contraceptive properties due to its anti-progestational activity.
    • Oral administration leads to rapid absorption, but first-pass metabolism reduces bioavailability.
    • Clinical trials show high success rates for early pregnancy termination (82-97%) and 100% efficacy as a post-coital contraceptive at specific doses.
    • Side effects include abdominal pain, nausea, and bleeding, though reduced doses may minimize these.

    Conclusions:

    • Mifepristone is a potent agent for early pregnancy termination and post-coital contraception.
    • Lower doses (≤200 mg) are effective for contraception and may reduce side effects in pregnancy termination regimens.
    • Further research into optimized dosing strategies can enhance its utility in reproductive healthcare.